These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 13588759)

  • 1. [Studies on the changes of the daily amount of tubercle bacilli present in sputum and its resistance against drugs, when patients have been treated with anti-tuberculous agents. III. Combined therapy with streptomycin, PAS and isoniazid].
    KAMEYAMA Y
    Kekkaku; 1958 Aug; 33(8):529-32; English abstract, 577-8. PubMed ID: 13588759
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on the changes of the daily amount of tubercle bacilli present in sputum & their resistance against drugs, when patients have been treated with anti-tuberculous agents. Iv].
    KAMEYAMA Y
    Kekkaku; 1958 Sep; 33(9):597-601; English abstract 646. PubMed ID: 13599180
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies on the changes of the daily amount of tubercle bacilli present in sputum and their resistance against drugs, when patients have been treated with antituberculous agents. II. Combined therapy with SM-PAS: PAS-INH: SM-INH: or sulfisoxazol-INH].
    KAMEYAMA Y
    Kekkaku; 1958 Jul; 33(7):457-63; English abstract 517-8. PubMed ID: 13564630
    [No Abstract]   [Full Text] [Related]  

  • 4. [Studies on the changes of the daily amount of tubercle bacilli present in sputum and its resistance against drugs, when patients have been treated with anti-tuberculous agents. I. Combined therapy with pyrazinamide and isonicotinic acid hydrazide].
    KAMEYAMA Y
    Kekkaku; 1958 Jun; 33(6):402-7; English abstract 444-5. PubMed ID: 13564622
    [No Abstract]   [Full Text] [Related]  

  • 5. [The attitude of tubercle bacilli in sputum, especially on the smear-positive & culture-negative cases. III. The influence of anti-tuberculous agents contained in sputum on culture for tubercle bacilli].
    NISHIMURA H
    Kekkaku; 1958 Feb; 33(2):102-5; English abstract, 129-30. PubMed ID: 13540020
    [No Abstract]   [Full Text] [Related]  

  • 6. [Epidemiological study on factors affecting the hospitalization period of patients with active tuberculosis].
    Fujino T; Fusegawa H; Nishiumi M; Okubo Y; Kakizaki T; Maejima K; Sugimori H
    Kekkaku; 2008 Aug; 83(8):567-72. PubMed ID: 18800648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Observation in changes in the count of tubercle bacilli present in the sputum of tuberculous patients treated with anti-tuberculous agents].
    KAMEYAMA Y
    Kekkaku; 1956 Jul; 31(7):438-41. PubMed ID: 13346863
    [No Abstract]   [Full Text] [Related]  

  • 8. [Individual differences in the pattern of resistance development of tubercle bacilli to streptomycin, PAS and isoniazid in tuberculous patients].
    TSUKAMURA M
    Kekkaku; 1960 Oct; 35():704-8. PubMed ID: 13778449
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevalence of initial drug resistance to M. tuberculosis in new sputum positive RNTCP patients.
    Dhingra VK; Rajpal S; Bhalla P; Yadav A; Jain SK; Hanif M
    J Commun Dis; 2003 Jun; 35(2):82-9. PubMed ID: 15562953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of kanamycin, ethionamide, PAS and cycloserine in multidrug-resistant pulmonary tuberculosis patients.
    Prasad R; Verma SK; Sahai S; Kumar S; Jain A
    Indian J Chest Dis Allied Sci; 2006; 48(3):183-6. PubMed ID: 18610675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature].
    Shishido Y; Nagayama N; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Komatsu H; Yotsumoto H
    Kekkaku; 2003 Nov; 78(11):683-9. PubMed ID: 14672045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The attitude of tubercle bacilli in sputum, especially on the smear positive and culture negative cases. I. Changes of the daily number of tubercle bacilli in sputum by chemotherapy].
    NISHIMURA H
    Kekkaku; 1956 Apr; 31(4):222-7. PubMed ID: 13320645
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative effects of combined and continuous streptomycin-PAS and streptomycin-PAS-isoniazid therapy on closure of tuberculous caverns].
    MOREAU F
    Acta Tuberc Belg; 1957 Oct; 48(5):382-6. PubMed ID: 13497820
    [No Abstract]   [Full Text] [Related]  

  • 15. Characteristics of mycobacterial populations found in the sputum of tuberculous patients after prolonged isoniazid therapy.
    PEIZER LR; CHAVES AD; WIDELOCK D
    Am Rev Respir Dis; 1960 Oct; 82():568-73. PubMed ID: 13733935
    [No Abstract]   [Full Text] [Related]  

  • 16. Response of patients infected with isoniazid-resistant tubercle bacilli to treatment with isoniazid plus PAS or isoniazid alone.
    DEVADATTA S; BHATIA AL; ANDREWS RH; FOX W; MITCHISON DA; RADHAKRISHNA S; RAMAKRISHNAN CV; SELKON JB; VELU S
    Bull World Health Organ; 1961; 25(6):807-29. PubMed ID: 13885865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of non-tuberculous pulmonary mycobacteriosis].
    Sakatani M; Nakajima Y
    Kekkaku; 2006 Jan; 81(1):35-50. PubMed ID: 16479999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug resistance profile of Mycobacterium tuberculosis isolates from pulmonary tuberculosis patients in Jos, Nigeria.
    Ani AE; Idoko J; Dalyop YB; Pitmang SL
    Trans R Soc Trop Med Hyg; 2009 Jan; 103(1):67-71. PubMed ID: 18789463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the cases discharging tubercle bacilli slightly. II. Influence of the work load on the discharge of tubercle bacilli.
    NAGASAWA S
    Kekkaku; 1954 Mar; 29(3):108-10; English abstract, 117-8. PubMed ID: 13175297
    [No Abstract]   [Full Text] [Related]  

  • 20. Changes in the count of tubercle bacilli present in the sputum of the patients treated with isonicotinic acid hydrazid in relation to the increase in the appearance of resistant bacilli.
    KOSAKAI N; MIKAMI J; NAKAJIMA S; TAKEMASA Y; ISHIKAWA T
    Kekkaku; 1954 Jan; 29(1):6-9. PubMed ID: 13164005
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.